Catalent Inc investor relations material
Catalent, Inc. is a global contract development and manufacturing organization and provider of research, analytical and clinical services. Catalent offers integrated discovery, development and manufacturing solutions including late stage clinical, sterile process design, commercial production and development solutions for biologics and over-the-counter health drug products. The company also provides comprehensive pharmaceutical services through established early phase development capabilities in small molecule API drug development and late phase clinical development capabilities in global multi-site clinical trials. In addition to biopharmaceuticals and OTC services, Catalent provides an integrated suite of R&D services, including protein chemistry and analytical testing to support non-biotechnology clients developing diagnostics for use in the clinical laboratory. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey.